Ning Kang

机构：Second Hospital of Tianjin Medical University, Tianjin Medical University · ORCID：0000-0003-1881-6748

发表论文 35 篇 · 总被引 824 次 · h-index 9

代表论文

• Lactic Acid and an Acidic Tumor Microenvironment suppress Anticancer Immunity (2020 · International Journal of Molecular Sciences · 被引 460)
• EZH2 Inhibition: A Promising Strategy to Prevent Cancer Immune Editing (2020 · Epigenomics · 被引 73)
• Mucosal Associated Invariant T Cells Were Activated and Polarized Toward Th17 in Chronic Obstructive Pulmonary Disease (2021 · Frontiers in Immunology · 被引 16)
• Influence of ADT on B7-H3 expression during CRPC progression from hormone-naïve prostate cancer (2023 · Cancer Gene Therapy · 被引 13)
• Preliminary study of the use of E6/E7mRNA detection in screening and triage management of HR-HPV infection during pregnancy (2021 · Annals of Translational Medicine · 被引 6)
• Exploring B7-H4’s Role in Prostate Cancer Dormancy after Androgen Deprivation Therapy: Extracellular Matrix Interactions and Therapeutic Opportunities (2025 · Molecular Cancer Research · 被引 4)